The Rapid ResponseTM Bladder Tumor Antigen Test Cassette is a lateral flow chromatographic immunoassay for the qualitative detection of bladder tumor antigen in human urine. It is intended to aid in the diagnosis and management of bladder cancer patients.
In practice, patient urine is added to the sample well and allowed to react with a colloidal gold-conjugated antibody. Interpretation of test results are: positive (two lines), negative (one line), invalid (no lines or no Control line).
Note:Could be customized under your request
1. High sensitivity, simple, easy.
2. Accuracy: >99%.
3. CE & ISO approved.
4. Specimen: Urine.
5. Model No:BZO-U02D
The BZO Rapid Test Device (Urine) detects Benzodiazepines through visual interpretation of color development
on the Device. Drug conjugates are immobilized on the test region of the membrane. During testing, the specimen
reacts with antibodies conjugated to colored particles and precoated on the sample pad. The mixture then
migratesthrough the membrane by capillary action, and interacts with reagents on the membrane. If there are
insufficient drug molecules in the specimen, the antibody-colored particle conjugate will bind to the drug conjugates,
forming a colored band at the test region of the membrane. Therefore, a colored band appears in the test region
when the urine is negative for the drug. If drug molecules are present in the urine above the cut-off concentration
of the test, they compete with the immobilized drug conjugate on the test region for limited antibody binding sites.
This will prevent attachment of the antibody-colored particle conjugate to the test region. Therefore, the absence
of a colored band at the test region indicates a positive result. The appearance of a colored band at the control
region serves as a procedural control, indicating that the proper volume of specimen has been added and
membrane wicking has occurred.
Allow test device,urine specimen,and/or controls to equilibrate to room temperature (15-30°C) prior to testing.
sold under the trade names Subutex,Buprenex,Temgesic and Suboxone, which contain Buprenorphine HCl alone or in combination with Naloxone HCl.Therapeutically, Buprenorphine is used as a substitution treatment for opioid addicts. Substitution treatment is a form of medical care offered to opiate addicts (primarily heroin addicts) based on a similar or identical substance to the drug normally used
Buprenorphine (BUP) Single Drug Test Cassette is a rapid urine drug screening test that can be performed without the use of an instrument.
Buprenorphine is a potent analgesic often used in the treatment of opioid addiction.The drug is sold under the trade names Subutex,Buprenex,Temgesic and Suboxone, which contain Buprenorphine HCl alone or in combination with Naloxone HCl.Therapeutically, Buprenorphine is used as a substitution treatment for opioid addicts. Substitution treatment is a form of medical care offered to opiate addicts (primarily heroin addicts) based on a similar or identical substance to the drug normally used.
Buprenorphine (BUP) Drug Test Device is an immunoassay based on the principle of competitive binding.Drugs which may be present in the urine specimen compete against the drug conjugate for binding sites on the antibody.
One Step Buprenorphine Drug Test Device is a rapid urine drug screening test that can be performed without the use of an instrument.During testing,a urine specimen migrates upward by capillary action. Buprenorphine, if present in the urine specimen below 10 ng/mL,will not saturate the binding sites of antibody-coated particles in the test.
The antibody-coated particles will then be captured by immobilized Buprenorphine conjugate and a visible colored line will show up in the test line region.
The colored line will not form in the test line region if the Buprenorphine level exceeds 10 ng/mL because it will saturate all the binding sites of anti-Buprenorphine antibodies.
A drug-positive urine specimen will not generate a colored line in the test line region because of drug competition,while a drug-negative urine specimen or a specimen containing a drug concentration lower than the cut-off will generate a line in the test line region.
To serve as a procedural control,a colored line will always appear at the control line region,indicating that proper volume of specimen has been added and membrane wicking has occurred.